Clinical trials

  • DACOTA TRIAL: A Randomized Phase III study of Decitabine (DAC) with or without Hydroxyurea (HY) versus HY in patients with advanced proliferative Chronic Myelomonocytic Leukemia (CMML)
    [Download German study flyer]

 

    • EUROPE TRIAL: Prospective validation of a predictive model of response to romiplostim in patients with IPSS low or intermediate-1 risk myelodysplastic syndrome (MDS) and thrombocytopenia
      [Download German study flyer]

 

    • SINTRA-REV TRIAL: Multicenter, randomized, double-blind, phase III study of Revlimid® (Lenalidomide) versus Placebo in patients with low risk myelodysplastic syndrome (low and intermediate-1 IPSS) with alteration in 5q and anemia without the need of transfusion
      [Download German study flyer]

 

    • SAMBA TRIAL:
      Single agent JNJ-56022473 in MDS and AML patients failing hypomethylating agent based therapy